Showing results (1761-1770 of 2,771) with videos related to
Sort By:
Pageof 278
Irish Journal of Medical Science|September 3, 2021
Sodium glucose co-transporter-2 inhibitor, Empagliflozin, is associated with significant reduction in weight, body mass index, fasting glucose, and A1c levels in Type 2 diabetic patients with established coronary heart disease: the SUPER GATE studySatilmis Bilgin, Ozge Kurtkulagi, Tuba Taslamacioglu Duman, et al.The West Indian Medical Journal|April 24, 2014
Mean platelet volume in nasal polypsG Aktas, M Sit, H Tekce, et al.The Journal of Experimental Medicine|December 6, 2003
Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damageAntje Diestel, Orhan Aktas, Dagmar Hackel, et al.Journal of Virological Methods|August 22, 2012
Application of the pseudo-plaque assay for detection and titration of Crimean-Congo hemorrhagic fever virusEngin Berber, Nurettin Canakoglu, Mustafa D Yoruk, et al.Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|June 18, 2021
Hashimoto's thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratioOzge Kurtkulagi, Burcin Meryem Atak Tel, Gizem Kahveci, et al.Virology Journal|January 4, 2013
Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virusNurettin Canakoglu, Engin Berber, Mustafa Ertek, et al.Andrologia|October 15, 2013
Protective effects of fish omega-3 fatty acids on doxorubicin-induced testicular apoptosis and oxidative damage in ratsR Uygur, C Aktas, F Tulubas, et al.Arquivos Brasileiros De Oftalmologia|September 20, 2018
Evaluation of renin and angiotensin II levels in pseudoexfoliation syndromeBurcin Kepez Yildiz, Zeynep Aktas, Nilay Yuksel, et al.Postgraduate Medicine|May 12, 2023
Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury?Gulali Aktas, Seyma Yilmaz, Didar Beyza Kantarci, et al.Drug Safety|January 5, 2019
Managing Risks with Immune Therapies in Multiple SclerosisMoritz Förster, Patrick Küry, Orhan Aktas, et al.Pageof 278